This article is part of the supplement: 11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells .

Proceedings

Signals for Hepatic Figrogenesis in Pediatric Cholestatic Liver Disease: Review and Hypothesis

Grant A Ramm , Anita C Hoskins , Sonia A Greco , Tamara N Pereira and Peter J Lewindon

The Hepatic Fibrosis Group, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland 4029, Australia

author email corresponding author email

Comparative Hepatology 2004, 3(Suppl 1):S5doi:10.1186/1476-5926-2-S1-S5

Published:	14 January 2004

First paragraph (this article has no abstract)

Cholestatic liver disease in children occurs as a result of either an alteration in hepatocyte bile formation or disruption of bile flow out of the hepatocyte through intrahepatic bile ductules or extrahepatic bile ducts [1]. Liver disease usually appears within the first few weeks following birth. A large number of disorders exhibit cholestatic jaundice in neonatal life including (a) numerous cholangiopathies, such as extrahepatic biliary atresia, cystic fibrosis (CF), choledochal cyst, alpha₁-Antitrypsin deficiency and Alagille's syndrome, (b) several abnormalities of the gall bladder, such as cholelithiasis and cholecystitis, and (c) bile acid transport disorders. The most commonly occurring form of neonatal cholestasis is biliary atresia, representing a relative frequency of approximately 30% [1]. In order to administer effective therapeutic intervention early diagnosis is critical. This can prove difficult as a number of phenotypic manifestations of the many different forms of neonatal cholestasis are similar and may even overlap.